Amrize AG (AMRZ)
| Market Cap | 20.78B -23.3% |
| Revenue (ttm) | 12.18B +5.0% |
| Net Income | 1.24B +5.8% |
| EPS | 2.23 +6.1% |
| Shares Out | 546.93M |
| PE Ratio | 16.82 |
| Forward PE | 14.75 |
| Dividend | $0.66 (1.75%) |
| Ex-Dividend Date | Aug 18, 2026 |
| Volume | 4,461,180 |
| Open | 37.90 |
| Previous Close | 37.32 |
| Day's Range | 37.60 - 38.51 |
| 52-Week Range | 35.79 - 65.94 |
| Beta | n/a |
| Analysts | Buy |
| Price Target | 47.20 (+24.8%) |
| Earnings Date | Oct 28, 2026 |
About AMRZ
Amrize AG engages in the provision of various building solutions for infrastructure, commercial, and residential construction markets in North America and Canada. It operates through two segments, Building Materials and Building Envelope. The Building Materials segment offers cement and aggregates, as well as ready-mix concrete, asphalt, and other construction materials. The Building Envelope segment provides advanced roofing and wall systems, including single-ply membranes, insulation, shingles, sheathing, waterproofing, and protective coating... [Read more]
Financial Performance
In 2025, Amrize AG's revenue was $11.82 billion, an increase of 0.95% compared to the previous year's $11.70 billion. Earnings were $1.19 billion, a decrease of -6.99%.
Financial StatementsAnalyst Summary
According to 20 analysts, the average rating for AMRZ stock is "Buy." The 12-month stock price target is $47.2, which is an increase of 24.80% from the latest price.
News
Amrize Announces Date for Third Quarter 2026 Financial Results
CHICAGO & ZUG, Switzerland--(BUSINESS WIRE)--Amrize (AMRZ) will release its third quarter 2026 financial results after the U.S. market closes on Wednesday, October 28, 2026, followed by a live webcast...
Amrize price target lowered to $48 from $52 at JPMorgan
JPMorgan analyst Elodie Rall lowered the firm’s price target on Amrize (AMRZ) to $48 from $52 and keeps a Neutral rating on the shares. The firm adjusted targets in the…
Amrize initiated with a Buy at Longbow
Longbow initiated coverage of Amrize (AMRZ) with a Buy rating and $48 price target
Amrize price target lowered to $32 from $48 at RBC Capital
RBC Capital analyst Anthony Codling lowered the firm’s price target on Amrize (AMRZ) to $32 from $48 and keeps an Underperform rating on the shares. The firm adjusted ratings and…
Amrize price target lowered to $35 from $48 at Truist
Truist lowered the firm’s price target on Amrize (AMRZ) to $35 from $48 and keeps a Hold rating on the shares as part of a broader research note on Construction…
Amrize price target lowered to $40 from $44 at Wells Fargo
Wells Fargo lowered the firm’s price target on Amrize (AMRZ) to $40 from $44 and keeps an Equal Weight rating on the shares. Discussing the Building Materials sector, the firm…
Amrize price target lowered to $50 from $58 at Citi
Citi lowered the firm’s price target on Amrize (AMRZ) to $50 from $58 and keeps a Buy rating on the shares. The firm adjusted targets in the construction materials space…
Amrize initiated with an Equal Weight at Barclays
Barclays analyst Adam Seiden initiated coverage of Amrize (AMRZ) with an Equal Weight rating and $55 price target The firm views the company’s portfolio as less favorable than CRH’s while…
Bear of the Day: Amrize (AMRZ)
Amrize (AMRZ) shares have been under considerable pressure as investors reassess the building-materials company's earnings trajectory, margins, and execution.
Amrize price target lowered to $56 from $64 at Deutsche Bank
Deutsche Bank analyst Jon Bell lowered the firm’s price target on Amrize (AMRZ) to $56 from $64 and keeps a Buy rating on the shares. The firm says cost pressures…
Amrize price target lowered to $42 from $57 at UBS
UBS lowered the firm’s price target on Amrize (AMRZ) to $42 from $57 and keeps a Neutral rating on the shares.
Amrize price target lowered to $55 from $62 at Oppenheimer
Oppenheimer lowered the firm’s price target on Amrize (AMRZ) to $55 from $62 and keeps an Outperform rating on the shares after touring Amrize’s Midlothian, TX cement operation, visiting DFW…
Amrize CEO Jan Philipp Jenisch Buys 30,000 Shares for $1.3 Million. Is This a Buy Signal?
Jan Philipp Jenisch purchased 30,000 shares for a total consideration of ~$1.3 million on September 2, 2026. The transaction involved shares equal to 1% of the total equity stake held before the filin...
Amrize Appoints Mario Gross as President of Building Envelope
CHICAGO & ZUG, Switzerland--(BUSINESS WIRE)--The Amrize (NYSE: AMRZ) Board of Directors has appointed Mario Gross as President, Building Envelope, effective September 11, 2026. Gross succeeds Jake Gos...
Amrize downgraded to Equal Weight from Overweight at Wells Fargo
Wells Fargo downgraded Amrize (AMRZ) to Equal Weight from Overweight with a price target of $44, down from $55. The firm downgraded three names in construction materials citing an “increasingly…
Amrize downgraded to Underperform from Neutral at BofA
BofA downgraded Amrize (AMRZ) to Underperform from Neutral with a price target of $40, down from $50. The firm cut the company’s estimates citing its slower growth outlook. Amrize’s growth…
Amrize downgraded to Neutral from Overweight at JPMorgan
JPMorgan downgraded Amrize (AMRZ) to Neutral from Overweight with a price target of $52, down from $57. The firm believes it will take some time for investors to regain confidence…
3 Stocks Facing New Pressure From Section 338 Tariffs on Canadian Goods
The bond market continues to flash warning signs as the Trump administration expands its trade war, and no, you haven't entered a time machine and returned to April 2025. This time, it's the Section 3...
Amrize Chief Strategy Officer Buys 2,510 Shares in $117,769 Transaction
The purchase involved 2,510 shares at $46.92 per share. The shares were acquired directly, with no reported indirect holdings or derivative conversions.
Amrize Ltd (AMRZ) Insider Buying: Chief Marketing & Corporate Affairs Officer Nollaig ...
Amrize Ltd (AMRZ) Insider Buying: Chief Marketing & Corporate Affairs Officer Nollaig Forrest Purchases 1,500 Shares
Amrize (AMRZ) Names Samuel J. Poletti as CFO Amid Strategic Leadership Shift
Amrize (AMRZ) Names Samuel J. Poletti as CFO Amid Strategic Leadership Shift
Amrize initiated with a Neutral at DA Davidson
DA Davidson initiated coverage of Amrize (AMRZ) with a Neutral rating and $50 price target The company’s visibility to positive catalysts remains limited over the next several quarters, the analyst…
Amrize names Sam Poletti CFO
Amrize’s (AMRZ) board of directors has appointed Samuel J. Poletti as Chief Financial Officer, effective August 24. Poletti succeeds Baris Oran, who is stepping down for personal reasons. The company…
Amrize Appoints Sam Poletti as Chief Financial Officer
CHICAGO & ZUG, Switzerland--(BUSINESS WIRE)--The Amrize (NYSE: AMRZ) Board of Directors has appointed Samuel J. Poletti as Chief Financial Officer, effective August 24. Poletti succeeds Baris Oran, wh...
Amrize price target lowered to $50 from $60 at BofA
BofA analyst Arnaud Lehmann lowered the firm’s price target on Amrize (AMRZ) to $50 from $60 and keeps a Neutral rating on the shares.